Viridian Therapeutics, Inc.\DE (VRDN) Non-Current Debt (2016 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) posted Non-Current Debt of $113.64 million for Q2 2026, up 820.0% from $12.35 million a year earlier and up 125.3% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Non-Current Debt (2016 - 2026) Analysis & Trends
At the end of FY2025, Viridian Therapeutics, Inc.\DE's Non-Current Debt came in at $49.94 million, up 142.6% from FY2024.
- In prior years, Viridian Therapeutics, Inc.\DE's Non-Current Debt was $20.58 million in FY2024 (+1.9%) and $20.21 million in FY2023.
- The Q2 2026 figure stands as the highest quarterly Non-Current Debt in data going back to Q4 2016.
- On a year-over-year basis, Non-Current Debt has increased in each of the last four quarters, with growth averaging 180.1% over the last six quarters.
- According to Business Quant data, Non-Current Debt for the three prior quarters was $50.44 million (Q1 2026), $49.94 million (Q4 2025) and $20.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | 2.33 Bn | - | 113.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 113.64 Mn |
| Mar 31, 2026 | 50.44 Mn |
| Dec 31, 2025 | 49.94 Mn |
| Sep 30, 2025 | 20.89 Mn |
| Jun 30, 2025 | 12.35 Mn |
| Mar 31, 2025 | 20.69 Mn |
| Dec 31, 2024 | 20.58 Mn |
| Sep 30, 2024 | 20.52 Mn |
| Jun 30, 2024 | 17.49 Mn |
| Dec 31, 2023 | 20.21 Mn |
| Sep 30, 2020 | 4.13 Mn |
| Jun 30, 2020 | 5.38 Mn |
| Mar 31, 2020 | 3.39 Mn |
| Dec 31, 2019 | 4.33 Mn |
| Sep 30, 2019 | 5.26 Mn |
| Jun 30, 2019 | 6.18 Mn |
| Mar 31, 2019 | 7.09 Mn |
| Dec 31, 2018 | 8.00 Mn |
| Sep 30, 2018 | 8.91 Mn |
| Jun 30, 2018 | 9.82 Mn |
API Access
Viridian Therapeutics, Inc.\DE Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();